Federal Register - March 9, 2021
Versión en texto ¿Qué es?Dateas es un sitio independiente no afiliado a entidades gubernamentales. La fuente de los documentos PDF aquí publicados es la entidad gubernamental indicada en cada uno de ellos. Las versiones en texto son transcripciones no oficiales que realizamos para facilitar el acceso y la búsqueda de información, pero pueden contener errores o no estar completas.
Fuente: Federal Register
Federal Register / Vol. 86, No. 44 / Tuesday, March 9, 2021 / Notices 1021, applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:
Controlled substance
Drug code
Schedule
Cocaine
Ecgonine
9041
9180
II
II
The company plans to manufacture the above-listed controlled substances in bulk for distribution to its customers.
No other activity for these drug codes is authorized for this registration.
William T. McDermott, Assistant Administrator.
FR Doc. 202104808 Filed 3821; 8:45 am BILLING CODE 441009P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Docket No. DEA803
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Groff NA
Hemplex LLC
Drug Enforcement Administration, Justice.
ACTION: Notice of application.
AGENCY:
The Drug Enforcement Administration DEA is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic classes of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA
registration.
SUMMARY:
Registered bulk manufacturers of the affected basic classes, and applicants therefor, may file written comments on or objections to the issuance of the proposed registration on or before May 10, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW 8701
Morrissette Drive, Springfield, Virginia 22152. To ensure proper handling of comments, please reference Docket No.
DEA803 in all correspondence, including attachments.
SUPPLEMENTARY INFORMATION: The Controlled Substances Act CSA
prohibits the cultivation and distribution of marihuana except by persons who are registered under the CSA to do so for lawful purposes. In
khammond on DSKJM1Z7X2PROD with NOTICES
DATES:
VerDate Sep<11>2014
17:03 Mar 08, 2021
Jkt 253001
accordance with the purposes specified in 21 CFR 1301.33a, DEA is providing notice that the entity identified below has applied for registration as a bulk manufacturer of schedule I controlled substances. In response, registered bulk manufacturers of the affected basic classes, and applicants therefor, may file written comments on or objections of the requested registration, as provided in this notice. This notice does not constitute any evaluation or determination of the merits of the application submitted.
The applicant plans to manufacture bulk active pharmaceutical ingredients APIs for product development and distribution to DEA-registered researchers. If the application for registration is granted, the registrant would not be authorized to conduct other activity under this registration aside from those coincident activities specifically authorized by DEA
regulations. DEA will evaluate the application for registration as a bulk manufacturer for compliance with all applicable laws, treaties, and regulations and to ensure adequate safeguards against diversion are in place.
As this applicant has applied to become registered as a bulk manufacturer of marihuana, the application will be evaluated under the criteria of 21 U.S.C. 823a. DEA will conduct this evaluation in the manner described in the rule published at 85 FR
82333 on December 18, 2020, and reflected in DEA regulations at 21 CFR
part 1318.
In accordance with 21 CFR
1301.33a, DEA is providing notice that on December 29, 2020, Groff NA
Hemplex LLC, 100 Redco Avenue, Suite A, Red Lion, Pennsylvania 173561436, applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:
Controlled substance Marihuana Extract
Drug code
Schedule
7350
I
William T. McDermott, Assistant Administrator.
FR Doc. 202104810 Filed 3821; 8:45 am BILLING CODE 441009P
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
13587
DEPARTMENT OF JUSTICE
OMB Number 11210197
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension Without Change, of a Previously Approved Collection; State Criminal Alien Assistance Program Section 241i of the Immigration and Nationality Act 8 U.S.C. 1231i Bureau of Justice Assistance, Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Department of Justice DOJ, Office of Justice Programs, Bureau of Justice Assistance, will be submitting the following information collection request to the Office of Management and Budget OMB for review and approval in accordance with the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and will be accepted 60 days until May 10, 2021.
FOR FURTHER INFORMATION CONTACT: If you have additional comments on the estimated burden to facilities covered by the standards to comply with the regulations reporting requirements, suggestions, or need additional information, please contact, Joseph Husted, telephone number 202 906
0387, Policy Advisor, Bureau of Justice Assistance, 810 Seventh Street NW, Washington, DC 20531 or by email at SCAAP@usdoj.gov.
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points:
Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;
Evaluate the accuracy of the agencys estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions that were used;
Evaluate whether and if so how the quality, utility, and clarity of the information collected can be enhanced; and Minimize the burden of the collection of information on those who are to respond, including use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of SUMMARY:
E:FRFM09MRN1.SGM
09MRN1